« Finavera Takes $28M for Two (Not $40M for Four) | Main | BioAmber Completes IPO »

        Add to Flipboard Magazine.

Save 31% on BioAmber’s IPO

Jim LaneBioamber logo

Will BioAmber complete its IPO?
As the industry waits, fingers crossed, the biosuccinic developer sweetens the pot with warrants, lower share prices.

In Canada, BioAmber has reduced the proposed price range for its IPO to $10-$12 per share, down from a $15-$17 range — as it seeks to keep the initial public offering on track.

Overall, the company now proposes to raise between $80 million and $110.4 million in the offering, now scheduled for May 13th according to the latest calendar from NASDAQ.

At the offering’s midpoint — and excluding the sale of up to 1.2 million shares in over-allotments — the company would raise $88 million, or 31% less than its previous SEC filing.

The company’s common stock has been approved for listing on the New York Stock Exchange, where it would trade under the symbol “BIOA” and the company also intends to list the stock on the Professional Segment of NYSE Euronext in Paris.

Credit Suisse, Societe Generale and Barclays are acting as bookrunners on the deal.

With the revised S-1A filing with the SEC yesterday, which revealed the lower target and can be read in its entirety here, the company said that each share of common stock would be sold in combination with a warrant to purchase half of one share of common stock at an exercise price of $11.00 per whole share of common stock.


BioAmber Inc. is the first industrial biotech company to attempt an IPO, defined as an “emerging growth company” under the Jumpstart Our Business Startups (JOBS) Act of 2012. More than 75 percent of companies that completed IPOs in the past year elected that designation — which provides, among other benefits, a five-year phase-in until the company has to fully comply with Sarbanes-Oxley provisions.

Complete coverage

BioAmber’s IPO: The 10-Minute Version.

We’ll explore the impact of the JOBS Act on IPOs, plus the impact of the warrants provisions in the revised filing — what it means, and how those work — in BioInvest Digest, where you can find a special report on BioAmber.

Jim Lane is editor and publisher  of Biofuels Digest where this article was originally published. Biofuels Digest is the most widely read  Biofuels daily read by 14,000+ organizations. Subscribe here.

was posted on AltEnergyStocks.com.

        Add to Flipboard Magazine.

Post a comment

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)

Search This Site

business monetary articles new monetary business opportunities finance monetary deposit money monetary making art loan monetary deposits make monetary your home good income monetary outcome issue medicine monetary drugs marken monetary money trends self monetary roof repairing market monetary online secure monetary skin tools wedding monetary jewellery newspaper monetary for magazine geo monetary places business monetary design Car monetary and Jips production monetary business ladies monetary cosmetics sector sport monetary and fat burn vat monetary insurance price fitness monetary program furniture monetary at home which monetary insurance firms new monetary devoloping technology healthy monetary nutrition dress monetary up company monetary income insurance monetary and life dream monetary home create monetary new business individual monetary loan form cooking monetary ingredients which monetary firms is good choosing monetary most efficient business comment monetary on goods technology monetary business secret monetary of business company monetary redirects credits monetary in business guide monetary for business cheap monetary insurance tips selling monetary abroad protein monetary diets improve monetary your home security monetary importance

Subscribe to this Blog

Enter your email address:

Delivered by FeedBurner

Subscribe by RSS Feed

Twitter Headlines



Certifications and Site Mentions

New York Times

Wall Street Journal

USA Today


The Scientist

USA Today

Seeking Alpha Certified

Seeking Alpha Certified

Twitter Updates